STAT

JANUARY 8, 2024

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.     The deal, disclosed as the biopharma field marked the first day of the annual J.P.

Drug Development 273

Drug Development Chemotherapy 273

PharmaVoice

JUNE 8, 2023

Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.

243

243

Pharmaceutical Commerce

MAY 17, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

104

104

STAT

NOVEMBER 20, 2023

and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. LONDON — The U.K. Continue to STAT+ to read the full story…

Drug Pricing 264

Drug Pricing 264

PharmaVoice

MAY 22, 2023

How these consumer and service companies are tapping into major trends in the biopharma industry.

264

264

Pharmaceutical Technology

NOVEMBER 2, 2022

The post China’s biopharma industry: the small molecule renaissance in rare diseases appeared first on Pharmaceutical Technology. In the future, China’s small molecule approvals for rare diseases are likely to continue its rapid growth.

Drug Development 59

Drug Development 59

Pharma Mirror

MAY 7, 2022

The post Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry appeared first on Pharma Mirror Magazine. Singapore, Avantor, Inc.

52

52

STAT

AUGUST 16, 2023

First Opinion , STAT’s platform for opinion and perspective essays, welcomes submissions about the biopharma industry, medical science and health care, and other topics related to the life sciences writ large. Here are general guidelines for submissions: Read the rest…

199

199

STAT

JANUARY 26, 2024

But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report. of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

Vaccines 278

Vaccines 278

STAT

FEBRUARY 23, 2024

Worldwide hiring in the biopharma industry has been slowing since mid-2022 , according to RBC Capital Markets analysts. This may reflect a greater focus on costs given inflation, IRA concerns, smaller companies trimming pipelines, biopharma layoffs, and near-term patent cliffs for the industry as a whole.

237

237

Pharmaceutical Commerce

OCTOBER 26, 2023

How setting action-based goals and cultivating partnerships will help overcome challenges associated with implementing a sustainable GHG strategy.

105

105

pharmaphorum

APRIL 4, 2024

Discover how AI-powered real-world evidence generation is revolutionising the biotech industry, providing valuable insights for biopharma companies to make informed decisions. Learn more about the impact of RWD on biotechs.

111

111

BioPharma Dive

JANUARY 16, 2024

A stock market run and a flurry of dealmaking have buoyed a sector that spent much of 2023 in a downturn. Can the momentum last?

65

65

STAT

DECEMBER 20, 2022

I enjoy thinking about and writing the Worst CEOs of Biopharma column every year. This list is about holding people and an industry accountable. It’s not because I’m mean or vindictive. It’s a public service!

246

246

STAT

APRIL 13, 2023

Jeremy Levin, CEO of Ovid Therapeutics, joins us to discuss a judge’s decision to overturn the FDA approval of an abortion pill and why he believes it’s the biggest threat to the biopharma industry in 50 years. Bernie Sanders has in his sights next. Read the rest…

185

185

Pharma Mirror

MAY 7, 2022

The post Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry appeared first on Pharma Mirror Magazine. Singapore, Avantor, Inc.

40

40

PharmaVoice

SEPTEMBER 29, 2023

Leaders who are going where no biopharma executive has gone before and changing the industry along the way.

130

130

PharmaTech

MARCH 7, 2024

Sean Knight, Simtra BioPharma Solutions, reacts to the company's global expansion efforts and investment in sterile fill/finish.

52

52

Outsourcing Pharma

APRIL 25, 2024

Last month, OSP was excited to write about One2Treat, a progressive startup specializing in digital health solutions, which has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.

80

80

STAT

MAY 25, 2023

government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. LONDON — The U.K.

Packaging 214

Packaging Pharmaceutical Manufacturing 214

Pharmaceutical Commerce

MARCH 18, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the positive signs from rising activity levels in biopharma M&A— and what the momentum may mean for industry dealmaking and partnership efforts in the months ahead.

105

105

Express Pharma

FEBRUARY 8, 2024

Agilent India has been honoured with the Best Bioprocessing Supplier Award: Analytical Services at the Biopharma Excellence Awards (BEA) 2024. The BEA awards are determined through industry voting of 30,000 professionals within the biopharma community. The focus is on enhanced speed, reduced cost, and superior quality.

Research Laboratories 96

Research Laboratories Vaccines 96

STAT

DECEMBER 8, 2022

Over the past few years, the biopharmaceutical industry has revved up efforts to diversify clinical trials. Rare disease experts at the Milken Institute Future of Health Summit on Tuesday had words of warning for biopharma: Don’t let equity efforts peter out. But clinical trials for rare diseases are still too often homogeneous.

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies 246

pharmaphorum

JANUARY 12, 2024

Discover how Veeva Systems is revolutionising closed loop marketing and connectivity in biopharma, from clinical to medical. Learn more about innovative solutions and insights from the Veeva Commercial Summit, featuring industry expert Chris Moore and the power of data-driven strategies.

102

102

Outsourcing Pharma

FEBRUARY 8, 2024

Outsourcing Pharma and BioPharma Reporter breaks down the key people on the move in the pharma industry. Enhanc3D Genomics, Cytomos and Cellular Origins are among the companies welcoming new faces to top jobs.

87

87

pharmaphorum

APRIL 4, 2024

The company said that it was stopping access to the drug for new patients immediately, while those already taking it would be able to continue on it via a free drug programme, after consultation with their doctors – a move that has garnered praise from across the biopharma industry.

94

94

Outsourcing Pharma

MARCH 26, 2024

Today (March 26) One2Treat, a new innovative start-up offering progressive digital health solutions, has launched a pioneering approach addressing two of the most strategic challenges in the biopharma industry today.

69

69

BioPharma Dive

MARCH 5, 2024

Following the sector’s best IPO start in three years, BioPharma Dive spoke with industry insiders about what they expect to see in the months ahead.

73

73

Outsourcing Pharma

SEPTEMBER 27, 2023

At Advanced Therapies Europe 2023, BioPharma Reporter caught up with ScaleReady's Jenny Stjernberg to discuss her work at the biotech company, her journey from academia to commercial and female representation in the cell and gene therapies industry.

103

103

STAT

SEPTEMBER 6, 2023

The private financing round, which was led by new investor GV (Google Ventures) and existing investors SR One and Atlas Venture, is among the bigger ones in biopharma worldwide this year. Nimbus’s announcement followed a big business deal that the company closed in February.

Vaccines 189

Vaccines 189

STAT

APRIL 9, 2024

… The numbers are in, and biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past , STAT explains. Venture-backed biopharma companies raised $6.8 billion in the first three months of the year, according to early data compiled by HSBC.

Vaccines 166

Vaccines 166

PharmExec

AUGUST 21, 2023

In this exclusive Q&A with Pharmaceutical Executive, Janice Chang, CEO of TransCelerate BioPharma, provides an inside look into her career journey, her work at the company, how the industry has changed in the last 10 years, as well as her thoughts on where the industry should put its efforts in clinical trials.

97

97

PharmExec

JULY 26, 2023

As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.

98

98

PharmExec

SEPTEMBER 8, 2023

With an organization's future commercial success under its remit, the NPP function has rapidly progressed to a prominent role in the biopharma industry—but evidence-generation strategies must evolve with an eye toward emerging trends and technologies.

98

98

Pharmaceutical Commerce

FEBRUARY 4, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

69

69

Pharmaceutical Commerce

APRIL 2, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

European Pharmaceutical Review

JUNE 7, 2023

The global biopharma industry’s resilience has decreased since 2021, a report by Cytiva has found. Using feedback from 1250 pharma and biopharma executives in 22 countries, the research sought to find out how has the biopharma industry has evolved over the past two years and what areas the industry should seek to improve.

Vaccines 76

Vaccines 76